<DOC>
	<DOCNO>NCT02844673</DOCNO>
	<brief_summary>To examine effect mobile-directly observed therapy ( mDOT ) adherence HU ( mDOT-HuA ) adult SCA Muhimbili National Hospital ( MNH ) Tanzania .</brief_summary>
	<brief_title>Mobile-Directly Observed Therapy Adherence Hydroxyurea</brief_title>
	<detailed_description>Background : Hydroxyurea ( HU ) demonstrate efficacious reduce complication individual Sickle Cell Anemia ( SCA ) poor adherence barrier improve outcome patient SCA . Directly Observed Therapy ( DOT ) show improve adherence various chronic disease limit data adult sickle cell anaemia ( SCA ) . Methods design : To examine effect mobile-directly observed therapy ( mDOT ) adherence HU ( mDOT-HuA ) adult SCA Muhimbili National Hospital ( MNH ) Tanzania.The mDOT-HuA study single centre , prospective , randomize , open label clinical trial . 100 participant SCA hemoglobin SS genotype , age ≥18 year , live urban Dar e Salaam able willing participate study . Participants divide two treatment arm ; 50 standard monitoring ( SM ) arm : receive fix dose HU therapy standard monitoring . 50 treatment mDOT arm : receive fix dose HU therapy standard monitoring mobile direct observe web base medication adherence monitoring system . The primary outcome adherence HU define medication possession ratio ≥80 end 3 month HU treatment mDOT monitoring . Secondary outcome efficacy HU treatment measure mean change fetal hemoglobin ( baseline end 3 month ) safety , measure proportion participant experience serious adverse event relate HU week 2 , 6 , 10 end 3 month . REDCap , open source software application use collect data use clinical research form . Conclusion : This project potential development novel strategy improve HU adherence SCA .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Age ≥18 year live urban Dar e Salaam Male female ( postmenopausal , sterile , use acceptable method contraception ) Negative urine pregnancy test Screening negative urine pregnancy test ( dipstick ) prior randomization dose Hemoglobin SS genotype Absolute neutrophil count &gt; 1,500/uL Platelet count &gt; 95,000/uL Serum creatinine &lt; 100 µmol/L ( 1.2 mg/dL ) Alanine transaminase ( ALT ) less two time upper limit normal Being able willing record submit video electronically Chronic transfusion program define participate schedule ( preplanned ) series transfusion prophylactic purpose hemoglobin A level &gt; 20 % total hemoglobin Hemoglobin &lt; 4.0 g/dL HIV positive Female planning become pregnant study period Serious mental ( include psychosis ) physical illness , , opinion Investigators would compromise participation study ( e.g . impaired mental capacity , alcoholism Any condition Investigators judge preclude safe participation study confound evaluation study outcome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Sickle cell disease</keyword>
	<keyword>Hydroxyurea</keyword>
	<keyword>Adherence</keyword>
	<keyword>randomize trial</keyword>
	<keyword>medication possession ratio</keyword>
</DOC>